E. Labonté

Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD.

Andrew G. Spencer, D. Charmot, M. Navre, 2015, Journal of the American Society of Nephrology : JASN.

Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders

Andrew G. Spencer, D. Charmot, K. Kozuka, 2016, Clinical pharmacology in drug development.

Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice.

P. Howles, P. Tso, Y. Ioannou, 2008, American journal of physiology. Gastrointestinal and liver physiology.

Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles.

P. Howles, Y. Ioannou, D. Hui, 2007, Biochimica et biophysica acta.

The phospholipase A2 inhibitor methyl indoxam suppresses diet‐induced obesity and glucose intolerance in mice

D. Charmot, M. Cope, D. Hui, 2009, British journal of pharmacology.

Expression of cholesterol 7alpha-hydroxylase restores bile acid synthesis in McArdle RH7777 cells.

L. Agellon, Q. Li, E. Labonté, 2000, Archives of biochemistry and biophysics.

Separation and quantitation of bile acids using an isocratic solvent system for high performance liquid chromatography coupled to an evaporative light scattering detector.

L. Agellon, E. Labonté, E. Torchia, 2001, Analytical biochemistry.

Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia.

K. Huggins, D. Hui, R. Kirby, 2006, Diabetes.

Postprandial lysophospholipid suppresses hepatic fatty acid oxidation: the molecular link between group 1B phospholipase A2 and diet‐induced obesity

P. Pfluger, M. Tschöp, R. Jandacek, 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.